financetom
Business
financetom
/
Business
/
Macquarie Sees Bank of Canada Cutting Rates by 50bps in December; Four Successive 25bps Cuts Next Year
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Macquarie Sees Bank of Canada Cutting Rates by 50bps in December; Four Successive 25bps Cuts Next Year
Nov 11, 2024 4:30 AM

07:00 AM EST, 11/11/2024 (MT Newswires) -- Employment in Canada increased by 14,500 in October, noted David Doyle, head of economics at Macquarie, following Friday's Labour Force Survey (LFS).

Despite the weak gain, the unemployment rate was steady at 6.5%, as the participation rate declined, driven by softness in younger workers and those of core working age.

This continues a trend that has been in place for the past year, where weak participation has suppressed the rise in unemployment, said Doyle. For context, if participation held steady from October 2023, the unemployment rate would now be 7.6%.

In a bright spot, hours worked rebounded by 0.3% month over month, after declining in August and September. This may support estimates of Q4 real gross domestic product growth, added the economist.

The population growth assumption moderated. This declined to 85,000 gains after averaging 110,000 rises in Q3, a reflection of the shifting immigration policy. The gap between the trend in employment growth and the breakeven level -- required to keep the employment rate constant -- remains substantial, suggestive of a widening output gap.

For the Bank of Canada ahead, Macquarie continues to expect another 50bps cut in December 2024, followed by four successive cuts of 25bps per meeting, with the overnight rate reaching 2.25% in June 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pre-surgery treatment with Bristol Myers combination therapy  leads to better skin cancer outcomes
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes
Jun 2, 2024
June 2 (Reuters) - Treatment with Bristol Myers Squibb's ( BMY ) immunotherapies Opdivo and Yervoy prior to surgery for patients whose skin cancer had spread to lymph nodes had better outcomes than those who did not get the drugs before node removal procedures, according to data from a late-stage trial released on Sunday. The study of 423 patients with...
Next Boeing CEO should understand past mistakes, airlines boss says
Next Boeing CEO should understand past mistakes, airlines boss says
Jun 2, 2024
DUBAI, June 2 (Reuters) - The next Boeing ( BA ) CEO should have an understanding of what led up to its current crisis and be prepared to look outside for examples of best industrial practices, the head of the International Air Transport Association said on Sunday. It is not for me to say who should be running Boeing (...
OPEC+ agrees to extend voluntary output cuts into Q3'24, talks continue, sources say
OPEC+ agrees to extend voluntary output cuts into Q3'24, talks continue, sources say
Jun 2, 2024
LONDON (Reuters) - OPEC+ has agrees to extend voluntary oil production cuts of 2.2 million barrels per day into the third quarter of 2024, two OPEC+ sources said on Sunday. Talks about cuts for the fourth quarter and 2025 continue, the sources said. (Reporting by OPEC Newsroom; Editing by Emelia Sithole-Matarise) ...
GSK blood cancer drug nearly halves risk of death in late-stage trial
GSK blood cancer drug nearly halves risk of death in late-stage trial
Jun 2, 2024
June 2 (Reuters) - GSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according to data from a late-stage study presented at a medical meeting on Sunday. In the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in...
Copyright 2023-2025 - www.financetom.com All Rights Reserved